Prognostic relevance of CCAs/Ph− in CML settled: comment on Issa et al, page 2084
In this issue of "Blood", Issa et al. report that patients with chronic-phase chronic myeloid leukemia (CML) in remission after treatment with tyrosine kinase inhibitors (TKIs) with clonal chromosomal aberrations (CCAs) in Philadelphia chromosome-negative (Ph−) metaphases had a significant...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 9, 2017
|
| In: |
Blood
Year: 2017, Jahrgang: 130, Heft: 19, Pages: 2046-2047 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2017-09-804054 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1182/blood-2017-09-804054 Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/130/19/2046 
|
| Verfasserangaben: | Rüdiger Hehlmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1571808086 | ||
| 003 | DE-627 | ||
| 005 | 20220814110343.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180409s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2017-09-804054 |2 doi | |
| 035 | |a (DE-627)1571808086 | ||
| 035 | |a (DE-576)501808086 | ||
| 035 | |a (DE-599)BSZ501808086 | ||
| 035 | |a (OCoLC)1341001898 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 245 | 1 | 0 | |a Prognostic relevance of CCAs/Ph− in CML settled |b comment on Issa et al, page 2084 |c Rüdiger Hehlmann |
| 264 | 1 | |c November 9, 2017 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.04.2018 | ||
| 520 | |a In this issue of "Blood", Issa et al. report that patients with chronic-phase chronic myeloid leukemia (CML) in remission after treatment with tyrosine kinase inhibitors (TKIs) with clonal chromosomal aberrations (CCAs) in Philadelphia chromosome-negative (Ph−) metaphases had a significantly worse survival than similar patients without CCAs. This study is notable for the large number of patients with CCAs (n=58) and the length of follow up (median, 7.6 years) (see figure). | ||
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 130(2017), 19, Seite 2046-2047 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Prognostic relevance of CCAs/Ph− in CML settled comment on Issa et al, page 2084 |
| 773 | 1 | 8 | |g volume:130 |g year:2017 |g number:19 |g pages:2046-2047 |g extent:2 |a Prognostic relevance of CCAs/Ph− in CML settled comment on Issa et al, page 2084 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/blood-2017-09-804054 |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.bloodjournal.org/content/130/19/2046 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180409 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |e 60000PH1037003489 |k 0/60000/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1571808086 |e 3005339041 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1571808086","person":[{"family":"Hehlmann","role":"aut","given":"Rüdiger","display":"Hehlmann, Rüdiger"}],"note":["Gesehen am 09.04.2018"],"language":["eng"],"name":{"displayForm":["Rüdiger Hehlmann"]},"relHost":[{"language":["eng"],"part":{"year":"2017","volume":"130","text":"130(2017), 19, Seite 2046-2047","extent":"2","pages":"2046-2047","issue":"19"},"pubHistory":["1.1946 -"],"note":["Gesehen am 21.04.2023"],"corporate":[{"display":"American Society of Hematology","role":"isb"}],"disp":"Prognostic relevance of CCAs/Ph− in CML settled comment on Issa et al, page 2084Blood","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Blood online"}],"recId":"266886647","title":[{"title_sort":"Blood","title":"Blood","subtitle":"journal of the American Society of Hematology"}],"id":{"issn":["1528-0020"],"eki":["266886647"],"zdb":["1468538-3"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1946-","publisher":"American Society of Hematology ; Saunders ; HighWire Press","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedKey":"1946"}]}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"November 9, 2017"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Prognostic relevance of CCAs/Ph− in CML settled","title":"Prognostic relevance of CCAs/Ph− in CML settled","subtitle":"comment on Issa et al, page 2084"}],"id":{"eki":["1571808086"],"doi":["10.1182/blood-2017-09-804054"]},"physDesc":[{"extent":"2 S."}]} | ||
| SRT | |a HEHLMANNRUPROGNOSTIC9201 | ||